Document Detail


Erythrocyte glutathione transferase: a potential new biomarker in chronic kidney diseases which correlates with plasma homocysteine.
MedLine Citation:
PMID:  21984376     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
The erythrocyte glutathione S-transferase (e-GST) is a member of a superfamily of inducible enzymes involved in cell detoxification that shows an increased expression in chronic kidney disease (CKD) patients. We propose a new automated analysis procedure for e-GST activity that has been validated in 72 CKD patients and 62 maintenance hemodialysis patients (MHD). Regression analysis was carried out to assess association between e-GST activity data, main clinical variables, and plasma homocysteine (Hcy), a modified sulfur amino acid known as potential risk factor for cardiovascular disease that is increased above normal levels in more than 90% of the uremic patients. An increased e-GST activity was confirmed in MHD patients (N = 62; 10.2 ± 0.4 U/gHb) compared with healthy subjects (N = 80; 5.8 ± 0.4 U/gHb), and as an original finding, a significant increase of e-GST activity was observed in pre-dialysis CKD patients with a positive correlation with disease severity weighted according to the four stages of "Kidney Disease Outcomes Quality Initiative" classification (7.4 ± 0.5, 8 ± 1, 9.5 ± 0.6, 12 ± 1 U/gHb, respectively). No correlation was found between e-GST activity and hemoglobin, transferrin, blood iron and the markers of systemic inflammation and renal function such as alpha-1 acid glycoprotein and high-sensitive C-Reactive Protein, beta-2 microglobulin and the index of malnutrition-inflammation PINI, while a significant correlation was observed for the first time between plasma Hcy and e-GST activity (r (2) = 0.64, P < 0.0001) in MHD patients. Hcy, however, was not identified as an inhibitor of e-GST enzyme. The results in this study suggest the potential for automated e-GST analysis as a valuable tool to further explore phase II-related uremic toxicity in CKD and MHD patients.
Authors:
Mariarita Dessì; Annalisa Noce; Kutayba F Dawood; Francesco Galli; Massimo Taccone-Gallucci; Raffaele Fabrini; Alessio Bocedi; Renato Massoud; Giorgio Fucci; Anna Pastore; Simone Manca di Villahermosa; Viviana Zingaretti; Giorgio Federici; Giorgio Ricci
Related Documents :
22744736 - A clinicopathological study of serotonin of sigmoid colon mucosa in association with ch...
22166506 - Adjuvant laboratory marker of kawasaki disease; nt-pro-bnp or hs-crp?
22772776 - Transcatheter aortic valve implantation in patients with and without concomitant corona...
21981606 - Peyronie's disease in teenagers.
19558966 - Hepatic anaplerotic outflow fluxes are redirected from gluconeogenesis to lactate synth...
17024796 - Risk factors for postoperative chest wound infections due to gram-negative bacteria in ...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-10-8
Journal Detail:
Title:  Amino acids     Volume:  -     ISSN:  1438-2199     ISO Abbreviation:  -     Publication Date:  2011 Oct 
Date Detail:
Created Date:  2011-10-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9200312     Medline TA:  Amino Acids     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Laboratory Medicine, University of Rome 'Tor Vergata', Rome, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Biophysical functionality in polysaccharides: from Lego-blocks to nano-particles.
Next Document:  Insulin resistance and the metabolism of branched-chain amino acids in humans.